Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
targeted cancer drugs
Biotech
Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Aum is moving on to oncology turf targeted by companies including Bayer and Roche, securing $27 million to advance inhibitors of MNK and TRK.
Nick Paul Taylor
Oct 13, 2021 8:40am
New cancer targets unveiled in map of protein interactions
Oct 1, 2021 9:00am
CRISPR pinpoints new AML target and its 'druggable pocket'
Aug 23, 2021 9:25am
Tyra Biosciences wants to bank $100M for an IPO
Aug 23, 2021 7:05am
Novel degrader of cancer-driving protein slows tumors in mice
Jul 23, 2021 10:00am
Combating BRCA-mutated tumors via a new pathway
Jun 17, 2021 11:00am
